CXCL8 and pulmonary arterial hypertension: JQ1 + resulted in non-significant decreases in the recruitment of NF-κB p65 to the κB binding site on the IL-6 (Fig. 7A and B) and IL-8 (Fig. 7C and D) promotor regions to near basal levels in control and PAH HPASMC.